References
- Keetch , D.W. , Catalona , W.J. and Smith , D.S. 1994 . “Serial prostatic biopsies in men with persistently elevated serum prostatespecific antigen levels” . J Urol. , 151 : 1571 – 1574 .
- Catalona , W.I. , Smith , D.S. , Wolfert , R.L. , Wang , T.I. , Rittenhouse , H.G. , Ratliff , T.L. and Nadler , R.B. 1995 . “Evaluation of percentage of free serum PSA to improve specificity of prostate cancer screening” . JAMA , 274 : 12 – 14 .
- Catalona , W.J. , Partin , A.W. , Slawin , K.M. , Brewer , M.K. , Patel , A. , Flanigan , R.C. , Richie , J.P. , deKernion , J.B. , Walsh , P.C. , Scardino , P.T. , Lange , P.H. , Herschmann , I.D. , Subong , E.N.S. , Petteway , J.C. , Parson , R.E. , Loveland , K.G. , Gaisor , G.H. and Southwick , P.C. 1997 . “A multicentre clinical trial evaluation of free PSA in the differentiation of prostate cancer from benign disease” . J. Urol. , 157 (Suppl.) UA
- Djavan , B. , Zlotta , A.R. , Byttebier , G. , Shariat , S. , Omar , M , Schulman , C.C. and Marberger , M. 1998 . “Prostate-specific antigen density of the transition zone for early detection of prostate cancer” . J. Urol. , 160 : 411 – 419 .
- Catalona , W.J. , Beiser , I.A. and Smith , D.S. 1997 . “Serum free prostate-specific antigen and prostate-specific antigen density measurements for predicting cancer in men with prior negative prostatic biopsies” . J. Urol. , 158 : 2162 – 2167 .
- Nixon , R.G. , Meyer , G.E. , Blasé , A.B. , Gold , M.H. and Brawer , M.K. 1998 . “Comparison of 3 investigational assays for the free form of prostate specific antigen” . J. Urol. , 160 : 420 – 425 .
- Catalona , W.J. , Partin , A.W. , Slawin , K.M. , Brawer , M.K. , Flanigan , R.C. , Patel , A. , Richie , J.P. , deKernion , I.B. , Walsh , P.C. , Scardino , P.T. , Lange , P.H. , Subong , E.N.S. , Petteway , J.C. , Parson , R.E. , Gaisor , G.H. , Loveland , K.G. , Loveland , K.G. and Southwick , P.C. 1998 . “Use of percentage of free prostatespecific antigen to enhance differentiation of prostate cancer from benign prostatic disease. A prospective multicentte clinical trial” . JAMA , 279 : 1542 – 1547 .
- Collins , G.N. , Rabb , G.M. , Hehir , M. , King , B. and Garraway , W.M. 1995 . “Reproducibility and observer variability of transrectal ultrasound measurements of prostate volume” . Ultrasound Med. Biol. , 21 : 1101 – 1105 .
- Catalona , W.J. , Hudson , M.A. , Scardino , P.T. , Richie , J.P. , Ahmann , F.R. , Flanigan , R.C. , deKernion , J.B. , Ratliff , T.L. , Kavoussi , L.R. , Dalkin , B.L. , Waters , W.B. , MacFarlane , M.T. and Southwick , P.C. 1994 . “Selection of optimal cut-offs for early detection of prostate cancer: receiver operating characteristic curves” . J. Urol. , 153 : 2037 – 2042 .
- Brawer , M.K. , Wener , M.H. , Rittenhouse , H.G. and Wolfert , R.L. 1996 . “Proportion of free form of PSA explains the majority of bias between IMx (Abbott) and Tandem (Hybritech) PSA assays” . J. Urol. , 155 : 416A
- Beduschi , M.C. and Oesterling , I.E. 1998 . “Percent free prostate-specific antigen: the next frontier in prostate-specific antigen testing” . Urology , 51 (Suppl.) : 98 – 109 .
- Littrup , P.J. , Kane , R.A. , Mettlin , C.J. , Murphy , G.P. , Lee , F. , Toi , A. , Badalament , R. and Babaian , R. 1994 . “Cost-effective prostate cancer detection. Reduction of low yield biopsies. Investigators of the American Cancer Society National Prostate Cancer Detection Project” . Cancer , 74 : 31 – 46 .
- Partin , A.W. , Catalona , W.I. , Southwick , P.C. , Subong , E.N. , Gasior , G.H. and Chan , D.W. 1996 . “Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: influence of tPSA, prostate volume, and age” . Urology , 48 : 55